F5, Inc. Investing Cash Flow decreased by 76.9% to -$18.67M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from -$20.60M to -$18.67M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -21.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$159.25M | -$191.64M | -$41.99M | $79.91M | $109.48M | $70.72M | $61.90M | -$7.14M | -$39.89M | -$6.45M | -$5.74M | -$9.97M | -$20.60M | -$25.11M | -$163.80M | -$10.56M | -$18.67M |
| QoQ Change | — | -20.3% | +78.1% | +290.3% | +37.0% | -35.4% | -12.5% | -111.5% | -459.0% | +83.8% | +10.9% | -73.7% | -106.6% | -21.9% | -552.3% | +93.6% | -76.9% |
| YoY Change | — | — | — | — | +168.7% | +136.9% | +247.4% | -111.5% | — | — | — | -39.8% | +48.3% | -289.4% | <-999% | -5.9% | +9.4% |